Srinivasan A - Search Results

1

Identification of the soluble in vivo metabolites of indium-111-diethylenetriaminepentaacetic acid-D-Phe1-octreotide.

Bass LA, Lanahan MV, Duncan JR, Erion JL, Srinivasan A, Schmidt MA, Anderson CJ. Bass LA, et al. Among authors: srinivasan a. Bioconjug Chem. 1998 Mar-Apr;9(2):192-200. doi: 10.1021/bc970158h. Bioconjug Chem. 1998. PMID: 9548534

2

Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.

Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. J Med Chem. 1999 Apr 22;42(8):1341-7. doi: 10.1021/jm980602h. J Med Chem. 1999. PMID: 10212119

3

In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.

Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. Nucl Med Biol. 1999 Apr;26(3):267-73. doi: 10.1016/s0969-8051(98)00105-x. Nucl Med Biol. 1999. PMID: 10363797

4

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL. Achilefu S, et al. Among authors: srinivasan a. J Med Chem. 2003 Jul 17;46(15):3403-11. doi: 10.1021/jm030081k. J Med Chem. 2003. PMID: 12852770

5

Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats.

Bugaj JE, Erion JL, Johnson MA, Schmidt MA, Srinivasan A. Bugaj JE, et al. Among authors: srinivasan a. Nucl Med Biol. 2001 Apr;28(3):327-34. doi: 10.1016/s0969-8051(01)00197-4. Nucl Med Biol. 2001. PMID: 11323245

6

Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.

Lewis JS, Wang M, Laforest R, Wang F, Erion JL, Bugaj JE, Srinivasan A, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. Int J Cancer. 2001 Dec 15;94(6):873-7. doi: 10.1002/ijc.1540. Int J Cancer. 2001. PMID: 11745491

7

Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.

Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwarz SW, Morris MM, Miller JP, Anderson CJ. Lewis JS, et al. Among authors: srinivasan a. Clin Cancer Res. 1999 Nov;5(11):3608-16. Clin Cancer Res. 1999. PMID: 10589778

8

A new method for the synthesis of tri-tert-butyl diethylenetriaminepentaacetic acid and its derivatives.

Achilefu S, Wilhelm RR, Jimenez HN, Schmidt MA, Srinivasan A. Achilefu S, et al. Among authors: srinivasan a. J Org Chem. 2000 Mar 10;65(5):1562-5. doi: 10.1021/jo991453t. J Org Chem. 2000. PMID: 10814125 No abstract available.

9

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

de Jong M, Breeman WA, Bakker WH, Kooij PP, Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt MA, Erion JL, Bugaj JE, Mäcke HR, Krenning EP. de Jong M, et al. Among authors: srinivasan a. Cancer Res. 1998 Feb 1;58(3):437-41. Cancer Res. 1998. PMID: 9458086

10

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

Kwekkeboom DJ, Bakker WH, Kooij PP, Konijnenberg MW, Srinivasan A, Erion JL, Schmidt MA, Bugaj JL, de Jong M, Krenning EP. Kwekkeboom DJ, et al. Among authors: srinivasan a. Eur J Nucl Med. 2001 Sep;28(9):1319-25. doi: 10.1007/s002590100574. Eur J Nucl Med. 2001. PMID: 11585290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,948 results

Search Page

Filters